6 Limitations of Annual Trust Studies for Corporate Reputation Management
Annual trust studies measure institutional trust, not how your company is perceived. 6 limitations, and what continuous measurement covers in between.
Reputation Intelligence for the Pharmaceutical Industry
RepTrak for Pharma
Leverage data-driven insights to monitor, measure, and manage your reputation in the Pharmaceutical industry.
Balancing Innovation with Public Trust.
While innovation drives progress, public skepticism around drug pricing, transparency, and ethics can erode trust. Negative perceptions not only damage stakeholder relationships but also impact market value. In this high-stakes environment, maintaining your brand's reputation is essential to long-term success.
Your Strategic Partner
RepTrak equips Pharma companies with the tools necessary to navigate complex reputational challenges. With continuous insights into public sentiment, media impact, and regulatory perceptions, RepTrak empowers teams to make data-driven decisions. Our team of experts partner with clients to manage risks, enhance trust, and stay ahead in an evolving industry.
Insights & Recommendations
Recommendations from experts who understand the nuances of the Pharma industry across global markets.
Proven Methodology
Scientifically validated approach, fine-tuned for Pharma, providing insights you can act on with confidence.
Historical Database
Leverage millions of global data points from over 20 years and learn from leaders who’ve transformed their reputation.
Built for Data-Driven Communication Teams
Insights and Recommendations from Industry Experts
Stakeholder Analysis
Gain insights into the perceptions and expectations of patients, regulators, healthcare professionals, and other key stakeholders.
Global & Local Pharma Insights
2024 Pharma Report
The 2024 Pharma Report offers a comprehensive view of the Pharmaceutical industry's reputation landscape, highlighting key trends and challenges across global markets. As public expectations continue to rise in the post-pandemic environment, Pharma companies are confronted with increased regulations, demands for quick innovations, and shaky relationships with critical stakeholders.
Fill out the form to learn more about what's driving the industry's reputation recovery — and where improvement is still needed.
Previous reports can be found here:
Fill out the form
Download the 2024 report here
Loading...
STAY UPDATED
See the latest reputation insights
Nike and the Cost of a Reputation Standing Still
Nike left the S&P 100 this week. Our Global RepTrak 100 data shows a parallel story: a steady Reputation Score covering a decade of lost ground.
5 Questions to Ask Any Reputation Intelligence Vendor Before You Sign
Picking a reputation intelligence vendor is a bigger decision than most RFPs treat it as. Five questions that separate published data from vague claims.
Your Priority List Has a Shelf Life
What your audience cares about moves, and a reputation program that only tracks performance has no way to see it.
From Annual Reputation Readout to A Monthly Management System
How often you measure reputation decides which questions the data can answer.
Banks Score Far Lower With AI Than With People. The Sources Explain Why.
ChatGPT and Gemini took the same reputation survey people do. Seven US banks scored 19 to 51 points lower with the machines. Here's what drove the difference.
Banking Communications Has a New Job: Underwriting Trust
The Informed General Public is extending banks less benefit of the doubt as regulatory oversight relaxes.
Measuring What Happens Between Coverage and Commerce
How to measure the stakeholder perceptions that sit between communications exposure and business outcomes.
Why Media Metrics Alone Don't Answer the C-Suite's Reputation Questions
Coverage data describes the information environment around a company. It was never designed to tell leadership what stakeholders concluded from it.
The Three Tests Every Campaign KPI Must Pass
Activity metrics and impact metrics aren't the same thing.
6 Limitations of Annual Trust Studies for Corporate Reputation Management
Annual trust studies measure institutional trust, not how your company is perceived. 6 limitations, and what continuous measurement covers in between.
Nike and the Cost of a Reputation Standing Still
Nike left the S&P 100 this week. Our Global RepTrak 100 data shows a parallel story: a steady Reputation Score covering a decade of lost ground.
5 Questions to Ask Any Reputation Intelligence Vendor Before You Sign
Picking a reputation intelligence vendor is a bigger decision than most RFPs treat it as. Five questions that separate published data from vague claims.
Your Priority List Has a Shelf Life
What your audience cares about moves, and a reputation program that only tracks performance has no way to see it.
From Annual Reputation Readout to A Monthly Management System
How often you measure reputation decides which questions the data can answer.
Banks Score Far Lower With AI Than With People. The Sources Explain Why.
ChatGPT and Gemini took the same reputation survey people do. Seven US banks scored 19 to 51 points lower with the machines. Here's what drove the difference.
Banking Communications Has a New Job: Underwriting Trust
The Informed General Public is extending banks less benefit of the doubt as regulatory oversight relaxes.
Measuring What Happens Between Coverage and Commerce
How to measure the stakeholder perceptions that sit between communications exposure and business outcomes.
Why Media Metrics Alone Don't Answer the C-Suite's Reputation Questions
Coverage data describes the information environment around a company. It was never designed to tell leadership what stakeholders concluded from it.
The Three Tests Every Campaign KPI Must Pass
Activity metrics and impact metrics aren't the same thing.